Medical Coordinator for ANTICOV project

Application deadline:

ISGlobal is seeking candidates for a Medical Coordinator/ position who is interested in taking over and managing activities of the clinical trial “An open-label, multicentre, randomised, adaptive platform trial of the safety and efficacy of several therapies, including antiviral therapies, versus control in mild / moderate cases of COVID-19” (ANTICOV) and their two ancillary studies (named ANTICOV-EPI and ANTICOV-IMMUNO) in two sites in Mozambique [Centro de Investigação em Saúde de Manhiça (CISM) & Centro de Investigação e Treino de Polana Caniço (CISPOC)]. The primary objective of the clinical trial is to compare the efficacy of alternative treatment strategies versus control on the risk of progression to severe respiratory disease in patients with mild/moderate COVID-19 disease. The recruitment of the ANTICOV trial is a 6 months period funded by the UNITAID. The study is led by DNDi, and ISGLOBAL is sponsoring two sites in Mozambique.